EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis

Infection and Immunity

Volumn 70, Issue 12, 2002, Pages 6646-6651

  Collin, Mattias ^a,e   Svensson, Mikael D ^b   Sjöholm, Anders G ^b   Jensenius, Jens C ^c   Sjöbring, Ulf ^b   Olsén, Arne ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; BACTERIAL ENZYME; FC RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; PROTEIN ENDOS; PROTEIN SPEB; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BACTERIAL SURVIVAL; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOLOGICAL TOLERANCE; MORTALITY; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFECTION; STREPTOCOCCUS PYOGENES; UPPER RESPIRATORY TRACT INFECTION;

BACTERIAL PROTEINS; BLOOD; COMPLEMENT ACTIVATION; CYSTEINE ENDOPEPTIDASES; GLYCOSIDE HYDROLASES; HUMANS; IMMUNOGLOBULIN G; OPSONIN PROTEINS; PHAGOCYTOSIS; RECEPTORS, FC; STREPTOCOCCUS PYOGENES;

EID: 0036892170     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.12.6646-6651.2002     Document Type: Article

References (43)

1. Åkesson, P., J. Cooney, F. Kishimoto, and L. Björck. 1990. Protein H - A novel IgG binding bacterial protein. Mol. Immunol. 27:523-531.
2. Åkesson, P., K.-H. Schmidt, J. Cooney, and L. Björck. 1994. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem. J. 300:877-886.
3. Berge, A., and L. Björck. 1995. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J. Biol. Chem. 270:9862-9867.
4. Chuang, P. D., and S. L. Morrison. 1997. Elimination of N-linked glycosylation sites from the human IgA1 constant region: Effects on structure and function. J. Immunol. 158:724-732.
5. Collin, M., and A. Olsén. 2001. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect. Immun. 69:7187-7189.
6. Collin, M., and A. Olsén. 2001. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 20:3046-3055.
7. Collin, M., and A. Olsén. 2000. Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol. Microbiol. 36:1306-1318.
8. Cooper, N. R. 1988. Laboratory investigation of complement proteins and complement receptors. Baillers Immunol. Allergy 2:263-293.
9. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
10. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry 20:2361-2370.
11. Dube, R., G. A. Rook, J. Steele, R. Brealey, R. Dwek, T. Rademacher, and J. Lennard-Jones. 1990. Agalactosyl IgG in inflammatory bowel disease: Correlation with C-reactive protein. Gut 31:431-434.
12. Fredlund, H., A. G. Sjöholm, B. Selander, E. Holmström, P. Olcén, and D. Danielsson. 1993. Serum bactericidal activity and induction of chemiluminescence of polymorphonuclear leukocytes: Complement activation pathway requirements in defense against Neisseria meningitidis. Int. Arch. Allergy Immunol. 100:135-143.
13. Gergely, J., H. H. Fudenberg, and E. van Loghem. 1970. The papain susceptibility of IgG myeloma proteins of different heavy chain subclasses. Immunochemistry 7:1-6.
14. Holder, I. A., and R. Wheeler. 1984. Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: Elastase, an IgG protease. Can. J. Microbiol. 30:1118-1124.
15. Jansen, H. J., D. Grenier, and J. S. Van der Hoeven. 1995. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens. Oral Microbiol. Immunol. 10:138-145.
16. Johnson, U., L. Truedsson, and B. Gustavii. 1983. Complement components in 100 newborns and their mothers determined by electroimmunoassay. Acta Pathol. Microbiol. Immunol. Scand. 91:147-150.
17. Kagawa, T. F., J. C. Cooney, H. M. Baker, S. McSweeney, M. Liu, S. Gubba, J. M. Musser, and E. N. Baker. 2000. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: An integrin-binding cysteine protease. Proc. Natl. Acad. Sci. USA 97:2235-2240.
18. Kilian, M., J. Mestecky, and R. E. Schrohenloher. 1979. Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect. Immun. 26:143-149.
19. Kilian, M., and M. W. Russell. 1999. Microbial evasion of IgA function, p. 241-251. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee (ed.), Mucosal Immunology. Academic Press, San Diego, Calif.
20. Lancefield, R. C. 1948. Differentiation of group A streptococci with a common R antigen into three serological types with special reference to the bactericidal test. J. Exp. Med. 106:525-544.
21. , Liu, T.-Y., N. P. Neumann, S. D. Elliott, S. Moore, and W. H. Stein. 1963. Chemical properties of streptococcal proteinase and its zymogen. J. Biol. Chem. 238:251-256.
22. Lukomski, S., S. Sreevatsan, A. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J. M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Investig. 99:2574-2580.
23. Male, C. J. 1979. Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoaiae. Infect. Immun. 26:254-261.
24. Mimura, Y., P. Sondermann, R. Ghirlando, J. Lund, S. P. Young, M. Goodall, and R. Jefferis. 2001. Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding. J. Biol. Chem. 276:45539-45547.
25. Nesbitt, S. A., and M. A. Horton. 1992. A nonradioactive biochemical characterization of membrane proteins using enhanced chemiluminescence. Anal. Biochem. 206:267-272.
26. Petersen, S. V., S. Thiel, and J. C. Jensenius. 2001. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38:133-149.
27. Plaut, A. G., J. V. Gilbert, M. S. Artenstein, and J. D. Capra. 1975. Neisseria gonorrhoeae and Neisseria meningitidis: Extracellular enzyme cleaves human immunoglobulin A. Science 190:1103-1105.
28. Radaev, S., and P. D. Sun. 2001. Recognition of IgG by Fcγ receptor: The role of Fc glycosylation and the binding of peptide inhibitors. J. Biol. Chem. 276:16478-16483.
29. Rademacher, T. W., S. W. Homans, D. L. Fernandes, R. A. Dwek, T. Mizuochi, T. Taniguchi, and A. Kobata. 1983. Structural and conformational analysis of immunoglobulin-derived N-linked oligosaccharides. Biochem. Soc. Trans. 11:132-134.
30. Rahman, M. A. A., and D. A. Isenberg. 1996. Glycbsylation of IgG in rheumatic disease, p. 101-118. In D. A. Isenberg and T. W. Rademacher (ed.), Abnormalities of IgG Glycosylation and Immunological Disorders. John Wiley & Sons Ltd., Chichester, United Kingdom.
31. Rudd, P. M., T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek. 2001. Glycosylation and the immune system. Science 291:2370-2376.
32. Shin, M. H., H. Kita, H. Y. Park, and J. Y. Seoh. 2001. Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G. Infect. Immun. 69:1599-1604.
33. Sjöholm, A. G., B. Selander, S. Östenson, E. Holmström, and C. Soderström. 1991. Normal human serum depleted of C1q, factor D and properdin: Its use in studies of complement activation. APMIS 99:1120-1128.
34. Sjöholm, A. G., L. Truedsson, and J. C. Jensenius. 2001. Complement pathways and meningococcal disease: Diagnostic aspects, p. 529-547. In A. J. Pollard and M. C. J. Maiden (ed.), Methods in Molecular Medicine, vol. 67. Human Press Inc., Totowa, N.J.
35. Steffensen, R., S. Thiel, K. Varming, C. Jersild, and J. C. Jensenius. 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J. Immunol. Methods 241:33-42.
36. Sutton, B. J., and D. C. Phillips. 1983. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. Biochem. Soc. Trans. 11:130-132.
37. Tack, B. D., and J. W. Prahl. 1976. Third component of human complement: Purification from plasma and physicochemical characterization. Biochemistry 15:4513-4521.
38. Tao, M. H., and S. L. Morrison. 1989. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143:2595-2601.
39. Tsai, P.-J., C.-F. Kuo, K.-Y. Lin, Y.-S. Lin, H.-Y. Lei, F.-F. Chen, J.-R. Wang, and J.-J. Wu. 1998. Effect of group A streptococcal cysteine proteinase on invasion of epithelial cells. Infect. Immun. 66:1460-1466.
40. Volanakis, J. E. 1998. Overview of the complement system, p. 9-32. In J. E. Volanakis and M. M. Frank (ed.), The Human Complement System in Health and Disease. Marcel Dekker Inc., New York, N.Y.
41. von Pawel-Rammingen, U., B. P. Johansson, and L. Björck. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21:1607-1615.
42. Vorup-Jensen, T., S. V. Petersen, A. G. Hansen, K. Poulsen, W. Schwaeble, R. B. Sim, K. B. Reid, S. J. Davis, S. Thiel, and J. C. Jensenius. 2000. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 165:2093-2100.
43. Wright, A., and S. L. Morrison. 1998. Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J. Immunol. 160:3393-3402.